Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health

Individuals drinking 2-3 cups of coffee per day have the lowest risk of depression and anxiety

by Vladimir Hedrih
September 11, 2023
in Mental Health, Psychopharmacology
(Image by StockSnap from Pixabay)

(Image by StockSnap from Pixabay)

Share on TwitterShare on Facebook
Stay informed on the latest psychology and neuroscience research—follow PsyPost on LinkedIn for daily updates and insights.

An analysis of the UK Biobank data revealed a J-shaped relationship between coffee consumption and the risk of depression and anxiety. Individuals who consumed 2-3 cups of coffee daily had the lowest risk of these mental disorders. However, risks increased for those who drank either fewer or more than this amount. The results were consistent regardless of whether individuals consumed ground coffee, milk coffee, or unsweetened coffee. The study was published in Psychiatry Research.

Both anxiety and depression disorders rank among the top causes of disability worldwide. Anxiety disorder manifests as excessive worry, fear, or apprehension, often intense and persistent, leading to physical symptoms such as a raised heart rate and muscle tension. Conversely, depression is characterized by enduring feelings of sadness, hopelessness, and a lack of interest in previously enjoyable activities. This disorder can also present physical symptoms, including appetite and sleep pattern changes. Both disorders can severely disrupt daily life.

Coffee consumption is a global practice. Previous studies have associated moderate coffee intake with reduced risks of ailments like type 2 diabetes, chronic liver disease, stroke, cancer, and a general lower risk of death. A U.S. study suggested that drinking a cup of coffee daily can reduce the risk of cardiovascular disease by 9%. Caffeine, a key component of coffee, is believed to influence mental health.

Study author Jiahao Min and his colleagues wanted to investigate the associations between coffee consumption and the development of depression and anxiety. They also wanted to know whether the association differed depending on the type of coffee (instant, ground, decaffeinated) and coffee additives (milk, sugar-sweetened, artificial-sweetened) consumed.

The researchers sourced their data from the UK Biobank, a comprehensive dataset comprising biometric, behavioral, and genetic data accessible to all researchers. This dataset contains data of over half a million adults from the general population of the United Kingdom.

The study focused on 152,821 participants who had responded to online mental health questionnaires as part of the UK Biobank data set. The team utilized data related to depression, anxiety, and coffee consumption. While data about anxiety and depression came from various sources, the coffee consumption data was obtained from online questionnaires completed between 2006 and 2010. These questionnaires included details about participants’ coffee preferences and their typical consumption.

The results indicated that 81% of participants consumed coffee. Among them, 41% drank 2-3 cups daily, 28% had one cup, and the remainder drank more.

Statistical analysis highlighted that individuals who consumed around three cups daily had the least risk of depression and anxiety. Those consuming over six cups daily faced a significantly heightened risk. Consuming 2-3 cups of ground coffee daily was linked to a reduced risk of depression and anxiety compared to non-coffee drinkers. Drinking 2-3 cups of instant coffee daily correlated with a reduced risk of depression, but not anxiety.

Consuming 1-3 cups of unsweetened coffee daily also reduced the risk of depression and anxiety. However, the consumption of coffee without milk, or coffee sweetened with sugar or artificial sweeteners, showed no significant relationship with the risk of these disorders.

“We found that moderate daily coffee consumption, especially at 2–3 cups of ground coffee, milk-coffee, or unsweetened coffee, was associated with a lower risk of incident depression and anxiety. Our findings support the recommendation that moderate coffee consumption could be part of a healthy lifestyle to prevent and manage depression and anxiety in the general population,” the study authors concluded.

The study makes an important contribution to the scientific understanding of health correlates of coffee consumption. However, readers should take into account that coffee consumption was self-reported and this was done only at a single time point at the start of the study. Coffee consumption habits can change and this might change the results. Also, researchers classified them into consumers of just a single type of coffee, while, in reality, individuals can and do drink different types of coffee on different occasions.

The study, “The association between coffee consumption and risk of incident depression and anxiety: Exploring the benefits of moderate intake”, was authored by Jiahao Min, Zhi Cao, Linlin Cui, Feimeng Li, Zuolin Lu, Yabing Hou, Hongxi Yang, Xiaohe Wang, and Chenjie Xu.

TweetSendScanShareSendPin14ShareShareShareShareShare

RELATED

Is gender-affirming care helping or harming mental health?
Mental Health

Is gender-affirming care helping or harming mental health?

May 20, 2025

A pair of studies offer differing perspectives on gender-affirming care: one finds surgery associated with increased psychiatric diagnoses, the other links hormone therapy with better mental health. The results suggest treatment context and measurement methods matter.

Read moreDetails
Scientists reveal startling impact of junk food on the brain’s reward center
Mental Health

Study finds “zombie” neurons in the peripheral nervous system contribute to chronic pain

May 20, 2025

Scientists have discovered that senescent sensory neurons accumulate with age and nerve injury, releasing inflammatory molecules that heighten pain sensitivity. The findings suggest that targeting these dysfunctional cells could reduce chronic pain, particularly in older adults.

Read moreDetails
Passive scrolling linked to increased anxiety in teens, study finds
Anxiety

Passive scrolling linked to increased anxiety in teens, study finds

May 20, 2025

New research shows that teens who spend more than two hours a day on screens—especially passively scrolling through content—are more likely to report anxiety and emotional or behavioral problems, even when accounting for age, gender, and existing vulnerabilities.

Read moreDetails
Psychedelic’s anti-anxiety effects can be separated from hallucinations by targeting specific brain circuits
Neuroimaging

Psychedelic’s anti-anxiety effects can be separated from hallucinations by targeting specific brain circuits

May 19, 2025

A mouse study published in Science shows that stimulating a specific set of brain cells activated by a psychedelic drug can reduce anxiety without triggering hallucination-like behavior, pointing to new possibilities for targeted mental health treatments.

Read moreDetails
Optimistic individuals are more likely to respond to SSRI antidepressants
Depression

Optimistic individuals are more likely to respond to SSRI antidepressants

May 19, 2025

People with depression who were more optimistic at the start of treatment—and whose optimism increased during treatment—were more likely to benefit from SSRIs, according to a recent study, raising the possibility of tailoring treatments based on psychological traits.

Read moreDetails
Scientists finds altered attention-related brain connectivity in youth with anxiety
Anxiety

Scientists finds altered attention-related brain connectivity in youth with anxiety

May 19, 2025

A large neuroimaging study has found that generalized anxiety disorder in youth is linked to increased connectivity in brain circuits involved in attention and emotion, and that these patterns may change with symptom remission.

Read moreDetails
From fixed pulses to smart stimulation: Parkinson’s treatment takes a leap forward
Parkinson's disease

From fixed pulses to smart stimulation: Parkinson’s treatment takes a leap forward

May 18, 2025

Once considered little more than reversible brain lesions, deep brain stimulators can now fine-tune their output using brain activity as a guide. This adaptive method may revolutionize how doctors treat neurological and psychiatric disorders.

Read moreDetails
New study sheds light on which post-psychedelic difficulties last longest and what helps people cope
Psychedelic Drugs

New study sheds light on which post-psychedelic difficulties last longest and what helps people cope

May 18, 2025

While many praise psychedelics for their therapeutic power, new research reveals that some users face long-lasting psychological challenges. This study explores the most common difficulties and the coping strategies people turn to for support and recovery.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Is gender-affirming care helping or harming mental health?

Study finds “zombie” neurons in the peripheral nervous system contribute to chronic pain

Therapeutic video game shows promise for post-COVID cognitive recovery

Passive scrolling linked to increased anxiety in teens, study finds

Your bodily awareness guides your morality, new neuroscience study suggests

Where you flirt matters: New research shows setting shapes romantic success

Psychedelic’s anti-anxiety effects can be separated from hallucinations by targeting specific brain circuits

New research reveals aging shifts gender stereotypes in unexpected ways

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy